Back to Search
Start Over
Response to Bevacizumab for the treatment of Rendu-Osler disease-A note of caution.
- Source :
-
Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2017 Jun; Vol. 37 (6), pp. 928. - Publication Year :
- 2017
- Subjects :
- Humans
Bevacizumab
Telangiectasia, Hereditary Hemorrhagic
Subjects
Details
- Language :
- English
- ISSN :
- 1478-3231
- Volume :
- 37
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Liver international : official journal of the International Association for the Study of the Liver
- Publication Type :
- Editorial & Opinion
- Accession number :
- 28544692
- Full Text :
- https://doi.org/10.1111/liv.13385